Skip Main Navigation
Page Content

Save This Event

Event Saved

Investor Spotlight: Emerillon Capital

JLABS @ Toronto

Thursday, May 4, 2017 from 10:30 AM to 1:00 PM (EDT)

Investor Spotlight: Emerillon Capital

Ticket Information

Ticket Type Sales End Price * Fee Quantity
Presentation & Lunch   more info May 3, 2017 CA$15.00 CA$1.51
Volunteer   more info Apr 27, 2017 Free CA$0.00
Media/Press   more info Apr 27, 2017 Free CA$0.00
* Prices include GST/HST

Share Investor Spotlight: Emerillon Capital

Event Details

Are you looking for a partner who can adapt to your venture project?

On May 4th, JLABS @ Toronto invites Emerillon Capital Investment Director, Nicola Urbani, to our “Investor Spotlight” to discuss:

  • Practical tips on what he looks for in a pitch
  • Emerillon Capital’s areas of interest – what are they investing in?
  • Case studies of successful investments
  • How to increase your chances of successful fundraising

Launched in Montreal in June 2013, Emerillon Capital (backed by its lead financial sponsor CM-CIC Investissement) is a venture capital fund with a patient capital and flexible approach. It is dedicated to supporting and investing in companies positioned in expanding sectors showing strong potential for growth. Emerillon is specialized in equity (or quasi-equity) investments and support of companies with strong technological expertise in their early development phases: pre-revenue, commercial start-up and first expansion.

If interested in meeting one-on-one with Nicola after his presentation, please fill out an application here:

10:30 AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking and Lunch
12:30 PM - 5:00 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on April 13, 2017.

$15 | General Public
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on May 3rd (or sold out).

JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Nicola Urbani | Investment Director, Emerillon Capital
A management and investment professional with a passion for innovation and broad experience (13 years) in venture capital investment in life sciences and cleantech industries. Worked in two different venture capital Fund managers with a total committed capital of over $400M: GeneChem management (with 4 different Funds targeting different stages and indications: GeneChem Technologies, GeneChem Therapeutics, AgeChem Financial, and AmorChem Financial) and Emerillon Capital. Served on numerous Boards and helped shape company strategies, C-level management teams and Board committees. Active involvement in the growth of several companies developing therapeutics through human clinical trials, and participated in numerous financing rounds with top tier Canadian and international venture capital Funds. Led several in-and out-licensing deals in life sciences and cleantech.
Immediately prior to joining Emerillon, Nicola was VP Commercialization at the McGill-affiliated Jewish General Hospital in Montreal, where he was responsible for technology transfer and the creation of companies. Nicola has a PhD in molecular genetics from McGill University and an MBA from Université du Québec à Montréal.
Connect with Nicola:   Connect on LinkedIn

Have questions about Investor Spotlight: Emerillon Capital? Contact JLABS @ Toronto

Save This Event

Event Saved

When & Where

JLABS @ Toronto
661 University Ave
Suite 1300
Toronto, ON M5G 1M1

Thursday, May 4, 2017 from 10:30 AM to 1:00 PM (EDT)

  Add to my calendar


JLABS @ Toronto

JLABS, part of Johnson & Johnson Innovation, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit

  Contact the Organizer
Investor Spotlight: Emerillon Capital
Things to do in Toronto Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.